Prevalence of gastrointestinal disorders in individuals with RASopathies: May RAS/MAP/ERK pathway dysfunctions be a model of neuropathic pain and visceral hypersensitivity?. Issue 11 (27th July 2022)

• Record Type: Journal Article
• Authors: Leoni, Chiara; Giorgio, Valentina; Stella, Giuseppe; Onesimo, Roberta; Triumbari, Elizabeth K. A.; Podagrosi, Maria; Kuczynska, Eliza; Vollono, Catello; Lindley, Keith J.; Zampino, Giuseppe
• Is Part Of: American journal of medical genetics. Volume 188:Issue 11(2022)
• Page Start: 3287
• Page End: 3293
• Publication Date: 2022-07-27
• Subjects: abdominal pain -- gastrointestinal disorders -- personalized medicine -- RASopathies; Medical genetics -- Periodicals; 616.14205
• DOI: 10.1002/ajmg.a.62917
• Languages: English
• ISSNs: 1552-4825

Abstract

Abstract: RASopathies are a group of neurodevelopmental syndromes caused by germline variants in genes of the Ras/MAP/ERK pathway. Growth failure, neurological involvement, and pain represent the main features of these conditions. ERK signaling cascade plays a crucial role in nociception and visceral pain and it is likely implicated in the genesis of neuropathic pain and maintenance of altered pain states. We studied the prevalence of abdominal pain and functional gastrointestinal (GI) disorders in a large sample of individuals with RASopathies. A brief pain inventory questionnaire and semi‐structured dedicated interview were used to investigate presence and localization of pain. A Rome IV questionnaire was used to screen for functional GI disorders. Eighty patients with clinical and molecular diagnoses of RASopathy were recruited (42 with Noonan syndrome; 17 with Costello Syndrome and 21 with cardio‐facio‐cutaneous syndrome). Overall, the prevalence of abdominal pain was 44% and prevalence of functional GI disorders was 78% with constipation, abdominal pain, and aerophagia being the most frequently detected ones. A significant association was found between pain and irritable bowel syndrome, functional constipation and aerophagia. Children with RASopathies have a high prevalence of functional gastrointestinal disorders. These children could represent a good in vivo model to study neuropathic pain, visceral hypersensitivity and gut‐brain axis disorders.